Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01808573 |
|---|---|
| Brief Title: | A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting (NALA) |
| First Submitted : | March 4, 2013 |
| First Submitted that Met QC Criteria : | March 7, 2013 |
| First Posted : | March 11, 2013 (Estimate) |
| Results First Submitted : | September 27, 2019 |
| Results First Submitted that Met QC Criteria : | December 9, 2019 |
| Results First Posted : | December 11, 2019 |
| Last Update Submitted that Met QC Criteria : | May 18, 2021 |
| Last Update Posted : | June 11, 2021 |